Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
- Christian Karime
- , Jing Wang
- , Gregory Woodhead
- , Kabir Mody
- , Charles T. Hennemeyer
- , Mitesh J. Borad
- , Daruka Mahadevan
- , Sreenivasa R. Chandana
- , Hani Babiker
Research output: Contribution to journal › Article › peer-review
10
Link opens in a new tab
Scopus
citations